Position in GH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$317,463
+$58,827 QoQ
Shares Held
2,116
-24.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#409
of 594 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026AlphaGrep UK Ltd holds $4,721,023 across 10 Diagnostics & Research names. GH ranks #6 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
2,630 | $1,384,537 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
1,237 | $620,182 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
2,747 | $530,775 | |
| 4 | MEDP |
Medpace Holdings, Inc.
|
880 | $466,039 | |
| 5 | DHR |
Danaher Corp /De/
|
2,122 | $404,198 | |
| 6 | GH |
Guardant Health, Inc.
This page
|
2,116 | $317,463 | |
| 7 | ILMN |
Illumina, Inc.
|
1,611 | $283,262 | |
| 8 | A |
Agilent Technologies, Inc.
|
1,859 | $246,930 |
All Filings in GH
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $317,463 | 2,116 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $258,636 | 2,800 | Shares | Sole | 2026-08-13 | |
| 2025-12-31 | $215,208 | 2,107 | Shares | Sole | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||